| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/24/2005 | WO2005004789A3 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 03/24/2005 | WO2005000886A3 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 03/24/2005 | WO2005000336A3 The use of caldag-gefi inhibitors as antithrombotic agents |
| 03/24/2005 | WO2005000332A3 Therapeutic agent for soft tissue sarcoma |
| 03/24/2005 | WO2005000215A3 Methods for treating pain |
| 03/24/2005 | WO2004112843A3 Odor control compositions and methods |
| 03/24/2005 | WO2004111270A3 Differential gene expression in schizophrenia |
| 03/24/2005 | WO2004111074A9 In vivo production of a clostridial neurotoxin light chain peptide |
| 03/24/2005 | WO2004109290A3 Methods for identifying modulators of kinesin activity |
| 03/24/2005 | WO2004108667A3 Formation of novel erythropoietin conjugates using transglutaminase |
| 03/24/2005 | WO2004103310A3 Methods and compositions for the treatment of metabolic disorders |
| 03/24/2005 | WO2004103266A3 Protein kinase c peptides for use in withdrawal |
| 03/24/2005 | WO2004098495A3 Medical devices and methods for inhibiting proliferation of smooth muscle cells |
| 03/24/2005 | WO2004096854A3 Insulin analogs having protracted time action |
| 03/24/2005 | WO2004096269A3 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors |
| 03/24/2005 | WO2004096176A3 Solid drug formulation and device for storage and controlled delivery thereof |
| 03/24/2005 | WO2004094673A3 Methods for monitoring drug activities in vivo |
| 03/24/2005 | WO2004094468A3 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| 03/24/2005 | WO2004093894A3 Use of b7-h3 as an immunoregulatory agent |
| 03/24/2005 | WO2004092379A3 Method for treatment of angiogenic disorders |
| 03/24/2005 | WO2004092378A3 Method for treatment of cancerous angiogenic disorders |
| 03/24/2005 | WO2004091438A3 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
| 03/24/2005 | WO2004084839A3 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 03/24/2005 | WO2004083240A3 Regulation of gene expression |
| 03/24/2005 | WO2004082702A8 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 03/24/2005 | WO2004078941A3 Modulation of gene expression using dna-rna hybrids |
| 03/24/2005 | WO2004078934A3 Targeting site-2 protease (s2p) for the treatment of pancreatic cancer |
| 03/24/2005 | WO2004078145A3 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 03/24/2005 | WO2004076650A3 Angiopoietin and fragments, mutants, and analogs thereof and uses of the same |
| 03/24/2005 | WO2004074318A3 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof. |
| 03/24/2005 | WO2004073641A3 Induced activation in dendritic cells |
| 03/24/2005 | WO2004072262A3 Cultured cd14+ antigen presenting cells |
| 03/24/2005 | WO2004071415A3 Method for treating elevated intraocular pressure, including glaucoma |
| 03/24/2005 | WO2004069867A3 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 03/24/2005 | WO2004069860A3 Isg15-conjugated proteins |
| 03/24/2005 | WO2004069175A3 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 03/24/2005 | WO2004066956A3 Uses of integrin alphavbeta3 antagonists |
| 03/24/2005 | WO2004065592A3 The crystal structure of a catalytically active portion of a set 7/9 histone methyltransferase and uses thereof |
| 03/24/2005 | WO2004065540A3 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
| 03/24/2005 | WO2004064788A3 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 03/24/2005 | WO2004063212A3 Organic compounds with biological action as thrombin inhibitors and use therof |
| 03/24/2005 | WO2004062588A3 Water-soluble polymeric bone-targeting drug delivery system |
| 03/24/2005 | WO2004062474A3 Smooth muscle cell differentiation with crp, srf and gata factors |
| 03/24/2005 | WO2004058165A3 Saposing c and receptors as targets for treatment of benign and malignant disorders |
| 03/24/2005 | WO2004053142A3 P53-associated parkin-like cytoplasmic protein, and related compositions and methods |
| 03/24/2005 | WO2004047731A3 Modulation of notch3 expression |
| 03/24/2005 | WO2004045531A3 Protection of cardiac myocardium |
| 03/24/2005 | WO2004041065A3 METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| 03/24/2005 | WO2004031347A3 Methods and compositions for soluble cpg15 |
| 03/24/2005 | WO2004024777A8 Hydroxyalkyl starch derivatives |
| 03/24/2005 | WO2004020591A3 Methods of use for novel human polypeptides encoded by polynucleotides |
| 03/24/2005 | WO2004014955A9 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003090687A9 Using heat shock proteins to increase immune response |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003080667A3 A novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/24/2005 | WO2003059291A3 Treatment of bone disorders with skeletal anabolic drugs |
| 03/24/2005 | WO2003045973A8 Peptides with growth inhibitory action |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | WO2002058450A3 Regulation of cell growth by muc1 |
| 03/24/2005 | WO2001068858A8 Human g protein-coupled receptors |
| 03/24/2005 | WO2000078801A9 Insulin-like growth factor agonist molecules |
| 03/24/2005 | US20050066381 Transgenic mouse comprising modified gene sequences associated with protein kinase c expression for use as tool in identifying modulator for treatment and prevention of cardiovascular and cardiomyopathic disorders |
| 03/24/2005 | US20050065333 Breast cancer-associated genes and uses thereof |
| 03/24/2005 | US20050065331 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065319 Combination method for treating viral infections |
| 03/24/2005 | US20050065203 use of an angiotensin-converting enzyme inhibitor, ramipril, to reduce the decline of beta -cell function, increase islet blood flow, lower aldosterone secretion, lower renal potassium wasting, increase pancreatic beta -cell perfusion, reduce insulin resistance in skeletal muscles, |
| 03/24/2005 | US20050065192 Synergistic mixture of methotrexate and integrin antigen or antibody |
| 03/24/2005 | US20050065184 Using angiotensin converting enzyme inhibitor; cardiovascular disorders; antidiabetic agentsd |
| 03/24/2005 | US20050065159 Penis enlargement |
| 03/24/2005 | US20050065107 Plasmids suitable for IL-2 expression |
| 03/24/2005 | US20050065104 therapy of atherosclerosis; cardiovascular disorders |
| 03/24/2005 | US20050065102 Medicinal compositions |
| 03/24/2005 | US20050065094 Synergistic mixture with other drug; side effect reduction |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065091 Containing antioxidant, free radical scavenger ; topical solution containing vitamin c, vitamin e |
| 03/24/2005 | US20050065090 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin |
| 03/24/2005 | US20050065089 Injecting a plasma containing protease, calcium , and thrombin into epidural spacing to activate transforming growth factor; therapy for bone disorders |
| 03/24/2005 | US20050065088 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone |
| 03/24/2005 | US20050065087 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein |
| 03/24/2005 | US20050065086 Adjust drug releasing characteristics, bioavailability of oral drug |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065083 Promoting survival of nerve cells; stimulating cell differentiation; amyotropic lateral scleerosis |
| 03/24/2005 | US20050065082 C-jun phosphorylation inhibitors |
| 03/24/2005 | US20050065080 Use of leptin in fertility |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050065078 Use of leptin for infant with low birth weight for prevention of obesity |
| 03/24/2005 | US20050065077 Anticarcinogenic agents |
| 03/24/2005 | US20050065076 Gamma three protease |
| 03/24/2005 | US20050065075 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability |
| 03/24/2005 | US20050065074 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 03/24/2005 | US20050065073 Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
| 03/24/2005 | US20050065072 Bactericides; immobilized |
| 03/24/2005 | US20050065071 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |